FDA 483 - Tianjin Asymchem Pharmaceuticals Co., Ltd. - December 06, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Tianjin Asymchem Pharmaceuticals Co., Ltd., an API manufacturer in TEDA West Tianjin, P.R. China, was cited for significant deficiencies in laboratory controls, including analytical method validation, release testing, and data validity. Additional observations noted inadequate procedures for establishing retest dates, failures in Quality Unit responsibilities, insufficient change control, and improper equipment surface construction. These issues indicate a lack of robust quality systems for API manufacturing.
ID · 93dc41ab-1075-4e3e-886b-7305749adeff